The press usually presents bio information from universities and...

The press usually presents bio information from universities and institutes at the Phase 1 or pre-clinical stages as breakthroughs.They seem particularly impressed by what the drug does to a mouse. These places can claim as big as they like without any likelihood of success or a stock market that scrutinises their claims.

They get sucked in by the prestigious names and those groups are usually marketing for donations and have pretty big outreach budgets accordingly. A small bio company at Phase 2 usually doesnt get an airing, no matter what they do or claim.